Biomarker: Non HDL Cholesterol
Overview
Non-HDL cholesterol measures the cholesterol carried by all potentially atherogenic lipoproteins and is calculated by subtracting HDL cholesterol from total cholesterol. It includes cholesterol in LDL, VLDL, IDL, remnant lipoproteins, and lipoprotein(a). Higher levels indicate a greater concentration of cholesterol in particles associated with atherosclerotic cardiovascular disease risk. The measure is clinically useful for cardiovascular risk assessment and can be calculated from routine lipid-panel results, including nonfasting samples.
Clinical Use Cases
- Screening for and monitoring dyslipidemia.
- Estimating the cholesterol burden in atherogenic lipoproteins.
- Assessing atherosclerotic cardiovascular disease risk.
- Supporting treatment decisions and monitoring response to lipid-lowering therapy.
- Evaluating patients with elevated triglycerides, diabetes, metabolic syndrome, or mixed dyslipidemia.
- Assessing pediatric cardiovascular risk and identifying children or adolescents who may require further evaluation.
- Population surveillance of abnormal lipid levels.
Specimen Types
- Serum from venous blood.
- Plasma from venous blood, typically collected with an acceptable anticoagulant such as EDTA or heparin.
Measurement Methods
- Calculation using the formula: non-HDL cholesterol = total cholesterol − HDL cholesterol.
- Total cholesterol measurement by an enzymatic colorimetric assay.
- HDL cholesterol measurement by a direct enzymatic assay or precipitation-based method, followed by calculation of non-HDL cholesterol.
- Automated clinical chemistry analyzer methods performed on serum or plasma.
Test Preparation and Influencing Factors
- Fasting is not routinely required for non-HDL cholesterol measurement because the calculation does not depend directly on triglyceride concentration.
- A fasting sample may be requested when triglycerides are markedly elevated, when a previous nonfasting result is abnormal, or according to local clinical protocols.
- Food intake can cause small changes in total and non-HDL cholesterol, but these changes are generally not clinically significant for routine testing.
- Lipid-lowering medications, including statins, ezetimibe, fibrates, and other therapies, can lower non-HDL cholesterol.
- Acute illness, recent major weight change, pregnancy, alcohol intake, and changes in usual diet or physical activity may affect lipid results.
- Results should be interpreted with the laboratory reference interval, the patient’s age, medical conditions, medications, and overall cardiovascular risk.
Synonyms
- Non-HDL cholesterol
- Non-HDL-C
- Non–high-density lipoprotein cholesterol
- Non-HDL cholesterol concentration
- Total cholesterol minus HDL cholesterol
- Atherogenic cholesterol
This information is provided for general educational purposes and is not medical advice. Biomarker information may describe testing methods, measurements, or interpretations that vary by laboratory or specific test. For details about a particular lab test, including biomarkers measured, specimen type, collection requirements, preparation, and turnaround time, please refer to the individual test description. Talk with a licensed health care provider about your results.